Homo sapiens Protein: NR5A1
Summary
InnateDB Protein IDBP-84851.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol NR5A1
Protein Name nuclear receptor subfamily 5, group A, member 1
Synonyms AD4BP; ELP; FTZ1; FTZF1; POF7; SF-1; SF1; SPGF8; SRXY3;
Species Homo sapiens
Ensembl Protein ENSP00000362690
InnateDB Gene IDBG-84849 (NR5A1)
Protein Structure
UniProt Annotation
Function Transcriptional activator. Seems to be essential for sexual differentiation and formation of the primary steroidogenic tissues. Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1. The SFPQ-NONO- NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional avtivity. Binds phosphatidylcholine (By similarity). Binds phospholipids with a phosphatidylinositol (PI) headgroup, in particular PI(3,4)P2 and PI(3,4,5)P3. Activated by the phosphorylation of NR5A1 by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation. {ECO:0000250, ECO:0000269PubMed:17210646}.
Subcellular Localization Nucleus {ECO:0000255PROSITE- ProRule:PRU00407, ECO:0000269PubMed:11479297}.
Disease Associations 46,XY sex reversal 3 (SRXY3) [MIM:612965]: A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. {ECO:0000269PubMed:10369247, ECO:0000269PubMed:11932325, ECO:0000269PubMed:17200175, ECO:0000269PubMed:17694559}. Note=The disease is caused by mutations affecting the gene represented in this entry.Adrenocortical insufficiency, without ovarian defect (ACIWOD) [MIM:184757]: A disorder that is characterized by severe 'slackness,' muscular hypotonia. There is decreased sodium, increased potassium and elevated ACTH. {ECO:0000269PubMed:11038323}. Note=The disease is caused by mutations affecting the gene represented in this entry.Premature ovarian failure 7 (POF7) [MIM:612964]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269PubMed:19246354}. Note=The disease is caused by mutations affecting the gene represented in this entry.Spermatogenic failure 8 (SPGF8) [MIM:613957]: An infertility disorder characterized by spermatogenesis failure and severe oligozoospermia. {ECO:0000269PubMed:20887963}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 28 experimentally validated interaction(s) in this database.
They are also associated with 12 interaction(s) predicted by orthology.
Experimentally validated
Total 28 [view]
Protein-Protein 26 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 2 [view]
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 12 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0003682 chromatin binding
GO:0003690 double-stranded DNA binding
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0003705 RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity
GO:0003707 steroid hormone receptor activity
GO:0003713 transcription coactivator activity
GO:0004879 ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity
GO:0005515 protein binding
GO:0005543 phospholipid binding
GO:0008270 zinc ion binding
GO:0019899 enzyme binding
GO:0043565 sequence-specific DNA binding
Biological Process
GO:0001553 luteinization
GO:0006355 regulation of transcription, DNA-templated
GO:0006357 regulation of transcription from RNA polymerase II promoter
GO:0006366 transcription from RNA polymerase II promoter
GO:0006367 transcription initiation from RNA polymerase II promoter
GO:0007267 cell-cell signaling
GO:0007538 primary sex determination
GO:0008584 male gonad development
GO:0008585 female gonad development
GO:0009888 tissue development
GO:0010259 multicellular organismal aging
GO:0010467 gene expression
GO:0022414 reproductive process
GO:0030154 cell differentiation
GO:0030325 adrenal gland development
GO:0030522 intracellular receptor signaling pathway
GO:0042445 hormone metabolic process
GO:0043401 steroid hormone mediated signaling pathway
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0050810 regulation of steroid biosynthetic process
GO:0051457 maintenance of protein location in nucleus
GO:2000020 positive regulation of male gonad development
GO:2000195 negative regulation of female gonad development
Cellular Component
GO:0005634 nucleus
GO:0005654 nucleoplasm
Protein Structure and Domains
PDB ID
InterPro IPR000536 Nuclear hormone receptor, ligand-binding, core
IPR001628 Zinc finger, nuclear hormone receptor-type
IPR001723 Steroid hormone receptor
IPR008946 Nuclear hormone receptor, ligand-binding
IPR016355 Steroidogenic factor 1
PFAM PF00104
PF00105
PRINTS PR00047
PR00398
PIRSF PIRSF002530
SMART SM00430
SM00399
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q13285
PhosphoSite PhosphoSite-Q13285
TrEMBL Q9H3V4
UniProt Splice Variant
Entrez Gene 2516
UniGene Hs.495108
RefSeq NP_004950
HUGO HGNC:7983
OMIM 184757
CCDS CCDS6856
HPRD 01702
IMGT
EMBL AB009577 AL137846 AL354979 AY542548 BC032501 CH471090 D88155 HQ692856 U32592 U76388
GenPept AAA75332 AAB53105 AAH32501 AAS48621 ADZ17367 BAA13546 BAB18655 CAI10872 CAI10959 EAW87591